Show simple item record

Evaluation of Chronic Hepatitis C Patients from Different Aspects Before the Use of Direct Acting Antivirals

dc.contributor.authorTabak, Fehmi
dc.contributor.authorSaltoglu, Nese
dc.contributor.authorKaya, Abdurrahman
dc.contributor.authorMete, Bilgul
dc.contributor.authorBalkan, Ilker Inanc
dc.contributor.authorYildiz Kaya, Sibel
dc.date.accessioned2021-03-03T15:50:20Z
dc.date.available2021-03-03T15:50:20Z
dc.date.issued2017
dc.identifier.citationYildiz Kaya S., Mete B., Kaya A., Balkan I. I. , Saltoglu N., Tabak F., "Evaluation of Chronic Hepatitis C Patients from Different Aspects Before the Use of Direct Acting Antivirals", VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, cilt.23, sa.1, ss.6-9, 2017
dc.identifier.othervv_1032021
dc.identifier.otherav_41157c89-a6ee-483c-9c45-c74d80fce1a8
dc.identifier.urihttp://hdl.handle.net/20.500.12627/47485
dc.identifier.urihttps://doi.org/10.4274/vhd.52724
dc.description.abstractObjective: Chronic hepatitis C (CHC) virus infection is one of the leading causes of chronic liver disease in all over the world. The prevalence of CHC is almost 0.5-1% in Turkey. Until recently, pegylated-interferon (PEG IFN) alpha in combination with ribavirin was the main treatment of CHC. The aim of the study was to evaluate the real life data of CHC patients.
dc.language.isoeng
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectTemel Tıp Bilimleri
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectTIP, GENEL & İÇECEK
dc.titleEvaluation of Chronic Hepatitis C Patients from Different Aspects Before the Use of Direct Acting Antivirals
dc.typeMakale
dc.relation.journalVIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume23
dc.identifier.issue1
dc.identifier.startpage6
dc.identifier.endpage9
dc.contributor.firstauthorID241810


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record